XML 40 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stockholders' Equity and Stock-Based Compensation (Tables)
12 Months Ended
Dec. 28, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock- Based Compensation
A summary of stock option activity under the stock award plans as of December 28, 2013 and changes during the twelve month period is as follows:
 
2013
 
Shares
 
Weighted
Average
Exercise
Price
Balance, beginning of year
983,680

 
$
5.26

Options forfeited/canceled
(424,830
)
 
5.48

Options exercised

 

Balance, end of year
558,850

 
$
5.09

Exercisable, end of year
558,850

 
 
Stock Options Outstanding and Exercisable
The following table summarizes information about stock options outstanding and exercisable at December 28, 2013:
 
 
Options Outstanding
 
Options Exercisable
Range of Exercise Prices
Number
Outstanding
 
Weighted
Average
Remaining
Contractual
Life (Years)
 
Weighted
Average
Exercise
Price
 
Number
Exercisable
 
Weighted
Average
Exercise
Price
$ 0.01—$ 3.50
130,000

 
2.00
 
$
3.49

 
130,000

 
$
3.49

$ 3.75—$ 4.82
328,850

 
1.00
 
4.23

 
328,850

 
4.23

$ 5.00—$ 8.03

 
2.23
 
5.40

 

 
5.40

$10.00—$10.00
100,000

 
1.00
 
10.00

 
100,000

 
10.00

 
558,850

 
1.23
 
$
5.09

 
558,850

 
$
5.09

Aggregate intrinsic value on December 28, 2013
$
182,643

 
 
 
 
 
$
182,643

 
 
NonVested Restricted Common Stock
A summary of the activity for nonvested restricted common stock awards as of December 28, 2013 and changes during the twelve months then ended is presented below:
 
 
Shares
 
Weighted
Average
Grant
Fair Value
Balance, December 29, 2012
2,283,048

 
$
4.76

Granted
2,135,000

 
3.22

Forfeited
(227,000
)
 
3.87

Vested
(1,216,900
)
 
3.46

Balance, December 28, 2013
2,974,148

 
$
4.25

Stock-Based Compensation Expense
The following table summarizes stock-based compensation expense related to employee stock options and nonvested restricted common stock awards for the fiscal years 2013, 2012 and 2011 (no tax benefits were recognized):
 
 
2013
 
2012
 
2011
Cost of product revenues
$
414,842

 
$
513,789

 
$
613,274

Research and development
423,548

 
366,443

 
577,514

Selling, general and administrative
3,365,018

 
3,606,758

 
2,732,840

Total
$
4,203,408

 
$
4,486,990

 
$
3,923,628